Are There Differences in Potency Between SGLT-2 Receptor Blockers Utilized in The Therapy of Heart Failure?
Frontiers in Medical Case Reports · 2021
DOI: 10.47746/fmcr.2021.2302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medical Case Reports, 2021. Verfasst von David Bell und 1 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
*Correspondence: David Bell Address: 1900 Crestwood Blvd, Suite 201, Irondale, AL 35210, USA e-mail : dshbell@yahoo.com Received: 22 March 2021; Accepted: 26 March 2021 Copyright: © 2021 Bell DS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Zitieren
APA
Bell, D., & Goncalves, E. (2021). Are There Differences in Potency Between SGLT-2 Receptor Blockers Utilized in The Therapy of Heart Failure?. Frontiers in Medical Case Reports. https://doi.org/10.47746/fmcr.2021.2302
Vancouver
Bell D, Goncalves E. Are There Differences in Potency Between SGLT-2 Receptor Blockers Utilized in The Therapy of Heart Failure?. Frontiers in Medical Case Reports. 2021. doi:10.47746/fmcr.2021.2302
BibTeX
@article{Bell2021,
author = {Bell, David and Goncalves, Edison},
title = {Are There Differences in Potency Between SGLT-2 Receptor Blockers Utilized in The Therapy of Heart Failure?},
journal = {Frontiers in Medical Case Reports},
year = {2021},
doi = {10.47746/fmcr.2021.2302}
}
EUVIMED